ELRIG and The Protein Society Announce Keynote Speakers for Protein Sciences in Drug Discovery 2026

• Prof Dame Carol Robinson (University of Oxford), Dr Andrew Doré (Isomorphic Labs) and Prof Paula Booth (King’s College London) to lead event taking place from 10–11 November at GSK Stevenage • Programme to focus on AI, machine learning and data-driven approaches across protein design, characterisation and therapeutic development

New Clearwater Report Finds 91% of Healthcare Organizations Cannot Verify AI Governance For Their Organization

HOPPR and CARPL.ai partner to give customers access to foundation models for building and fine-tuning radiology AI

CARPL.ai, the world's largest radiology AI marketplace and enterprise imaging AI platform, today announced a partnership with HOPPR, a company transforming how AI is developed for medical imaging. The collaboration gives healthcare providers access to HOPPR's foundation models to securely develop, fine-tune, and deploy custom radiology AI applications through the CARPL platform.

CRB releases new Horizons: Life Sciences report

CRB’s newly released Horizons: Life Sciences 2026 report finds manufacturers expanding their pipelines, investing in advanced technologies, and committing to future capacity despite regulatory challenges, geopolitical pressures and rising costs.

ArmorCode Study Highlights the Growing Gap Between AI-Powered Vulnerability Discovery and Risk Reduction

Industry Leading RBQM Event Returns for 2026

CluePoints sponsored RBQMLive 2026 will explore shift from adoption to operational maturity.

CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development

CellCarta today announced a strategic partnership with Waters Corporation creating a framework to jointly pursue companion diagnostic and next-generation flow cytometry opportunities with pharmaceutical and biotechnology companies.

Shift Bioscience publication increases confidence in AI virtual cells for novel target discovery

- Nature Biotechnology publication details improved calibration framework for deep learning-based genetic perturbation models - Peer-reviewed study will inform large-scale screen to identify inhibition targets with applications in rejuvenation and age-related disease treatment

Baylor Genetics Selected as the Lead Sequencing Partner for Florida’s Sunshine Genetics Pilot Program Launch

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it has been chosen as a strategic sequencing partner for Florida’s Sunshine Genetics Pilot Program and will serve as the lead sequencing provider at launch.

New Peer-Reviewed Study Demonstrates Amprion's Seed Amplification Assay Can Differentiate Multiple System Atrophy from Parkinson's Disease Using Skin Biopsy Samples

Amprion announced publication of a new peer-reviewed study demonstrating that its seed amplification assay using skin biopsy samples can differentiate multiple system atrophy from Parkinson's disease, representing an important step toward expanding less invasive biomarker testing for neurodegenerative disease. The findings, published in npj Parkinson's Disease, support ongoing development of the company's skin-based assay for research use and future clinical commercialization.

CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and Companion Diagnostic Programs Across Drug Development

CellCarta and Imagene AI today announced an expanded collaboration to provide a coordinated path for biopharma companies to validate, deploy, and scale AI-powered biomarker and companion diagnostic programs.

Three new commercial appointments for Symbiosis to drive international growth

Amprion and Prema Cognition Partner to Advance Multimodal Assessment of Neurodegenerative Disease

Amprion and Prema Cognition have announced a collaboration to advance a more comprehensive approach to neurodegenerative disease assessment by combining digital cognitive testing with molecular biomarker analysis. Together, the companies aim to support earlier identification of at-risk individuals and more informed clinical decision-making through complementary technologies.

Ceryx Medical appoints Professor Zaheer Yousef OBE as Chief Medical Officer

Ceryx Medical has appointed Professor Zaheer Yousef OBE as Chief Medical Officer. Professor Yousef is a consultant cardiologist at the University Hospital of Wales and was principal investigator on RSA-Pace, Ceryx's multi-centre study of its respiratory sinus arrhythmia pacing technology. He joins as the company moves towards a clinical study designed to demonstrate the full clinical benefit of its implantable device in people living with heart failure.

PubHive Named Best Life Sciences Workflow SaaS Platform 2026

PubHive wins Best Life Sciences Workflow SaaS Platform 2026 for connected literature, PV, evidence, AI-assisted review, and traceable workflows.

Systech Launches New All-in-One Pharma Packaging and Serialization Stations

New Survey Finds Patients Want Home-Based Cardiac Rehab, While Coverage and Clinical Oversight Drive Participation

Vivalink's survey of more than 150 adults with cardiac conditions emphases the demand for flexible, home-based cardiac rehabilitation programs, with insurance coverage and clinical oversight key factors driving participation.

ViewsML Appoints Digital Pathology Executive Michael Rivers to Board of Directors

ViewsML, a leader in AI-powered virtual biomarker staining, today announced the appointment of Michael Rivers to its Board of Directors. Rivers brings more than 20 years of experience leading the commercialization of global diagnostic and digital pathology portfolios, including experience advancing AI-enabled technologies from development through regulatory clearance and market adoption.

The University of Turin Adopts Openwater’s Open-Motion Device to Study Muscle Blood Flow and Vascular Responses

Researchers in the University’s Integrative Physiology Lab will evaluate Openwater’s wearable platform for studying muscle blood-flow dynamics and vascular responses to nervous system activity, with potential future applications in noninvasive neural communication

Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline